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Antimicrobial activityBoscia albitrunca is a medicinal plant widely used in the management of eye related ailments and haemorrhoid
diseases. Repeated column fractionation of the n-butanol fraction of a 20% aqueous methanol leaf extract of
B. albitrunca on silica gel and Sephadex LH-20 columns afforded a phenolic compound identiﬁed asmartynoside.
Structure elucidation of the isolated compoundwas carried out using spectroscopic techniques. The extracts and
isolated compoundwere evaluated for antimicrobial activities using themicro dilution technique. All the extracts
and compoundwere active against the testedGram-positive, Gram-negative bacteria and fungi.Minimum inhib-
itory concentration (MIC) values for extracts ranged from390.0 to 6250 μg/mL andmartynoside isolated from the
butanol fraction was the most active with the lowest MIC values of 7.81 and 31.2 μg/mL against B. subtilis and
K. pneumoniae respectively. The activity demonstrated by the extracts and martynoside obtained from
B. albitrunca against tested bacteria and fungi suggests that they could be helpful in the management of eye
infections.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
The search for new effective antimicrobial agents is necessary due to
the increase of microbial resistance to currently available drugs. This is
caused by factors such as poor compliance and inappropriate use of
medication amongst others. Herbs contain copious amounts of second-
ary metabolites that could be exploited to prevent microbial infections
(Kuete et al., 2009). It is estimated that more than 80% of health care
needs in developing countries are met through traditional health care
practices (WHO, 2002). Of the eight Boscia species occurring in southern
Africa, Boscia albitrunca (Burch.) Gilg & Benedict (Capparaceae) ismost-
ly used in treatment of a variety of diseases. It is commonly known as
shepherd's tree (Bothma, 1982). The green fruits are used to treat epi-
lepsy. Extracts of the leaf extracts are applied to the inﬂamed eye and
the extracts of the roots are used for the treatment of haemorrhoids
and sometimes eaten either dry or are roasted and then ground to
make a substitute for coffee or pounded to obtain a white meal for por-
ridge (Coates, 1983; Hutchings et al., 1996). In Namibia, the leaves and
roots of the plant are used for the treatment of constipation and head-
ache (Cheikhyoussef and Embashu, 2013).
In this study, we have investigated the in vitro antimicrobial activi-
ties of the crude extract, fractions and an isolated compound from
B. albitrunca.hts reserved.2. Materials and methods
2.1. General
Thin layer chromatographic analyses were performed at room tem-
perature using pre-coatedplates (MERCK, silica gel 60F254 0.2 thickness).
Compounds were detected by viewing the TLC plates under ultraviolet
light (254 and 366 nm). Open column chromatography was carried out
using Sephadex LH-20 and silica gel. Nuclear Magnetic Resonance
(NMR) data were obtained using a Brucker spectrometer (400 MHz).
Chemical shifts are expressed in parts per million (ppm).
2.2. Sample collection
Leaves of B. albitruncawere collected inNovember 2012 from theUni-
versity of KwaZulu-Natal (UKZN) Botanical Garden, Pietermaritzburg,
SouthAfrica. The plantwas identiﬁedbyMrsAlisonYoung (Horticulturist,
UKZN) and a voucher specimen was prepared (S Pendota 2) and lodged
in the Bews Herbarium, (NU). The leaves were dried at 50 °C, ground
into a powder using an Ultra-Centrifugal Mill (ZM 200, Retsch®,
Germany) and stored at room temperature in airtight containers
under dark conditions for 1 month.
2.3. Extraction
The powdered plant material (1 kg) was extracted with 8 L of 20%
aqueous methanol at room temperature for 24 h and ﬁltered. The
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volume. This afforded a crude extract of the plant material (600 mL).2.4. Solvent partitioning of the crude extract
The concentrated crude extract was sequentially extracted with
n-hexane (3 x 800 mL), dichloromethane (3 × 800 mL), ethyl acetate
(3 × 1 L) and ﬁnally n-butanol (500 mL). The solvent fractions were
concentrated to dryness in vacuo to afford four solvent fractions: hexane
(Hex), dichloromethane (DCM), ethyl acetate (EtOAc) and n-butanol
fractions.2.5. Isolation of compound from B. albitrunca leaf extracts
The n-butanol fraction (4.0 g)was fractionated on a silica gel column
using DCM/EtOAc (9:1) followed by an increasing gradient of EtOAc up
to 100% and then up to 10%MeOH in EtOAc. Four fractions (A1–A4)were
obtained based on TLC analysis. Further column fractionation of fraction
A2 on Sephadex LH-20 using EtOAc/MeOH (9:1) followed by an increas-
ing gradient of methanol up to 20% and subsequent TLC analysis using
DCM/MeOH (9:1) resulted in the isolation of compound 1 (37 mg).2.6. Antibacterial activity
The minimum inhibitory concentration (MIC) of the crude extract,
fractions and isolated compound of B. albitruncawas determined using
the micro-dilution assay in 96-well micro-plates (Eloff, 1998). One hun-
dred microlitres of each resuspended sample (50 mg/mL for fractions
and 1.0 mg/mL for compound) in 80% ethanol were two-fold serially di-
luted with sterile distilled water, in duplicate in a 96-well micro-plate
for each of the four bacteria. A similar two-fold serial dilution of neomycin
(Sigma) (0.1 mg/mL) was used as a positive control against each bacteri-
um.Water, 80% ethanol and bacteria-free broth were separately included
as negative controls. Overnight cultures (incubated at 37 °C in a water
bath with shaking) of four bacterial strains: two Gram-positive (Bacillus
subtilis ATCC 6051 and Staphylococcus aureus ATCC 12600) and two
Gram-negative (Escherichia coli ATCC 11775 and Klebsiella pneumoniae
ATCC 13883) were diluted with sterile Mueller–Hinton (MH) broth
(1mL bacteria per 50mLMH, approximately 106 CFU/mL ofmicroorgan-
isms). One hundred microlitres of each bacterial culture were added
to each well. The plates were covered with paraﬁlm and incubated
overnight at 37 °C. Bacterial growth was tested by adding 50 μL of
0.2 mg/mL p-iodonitrotetrazolium chloride (INT) to each well and
the plates incubated at 37 °C for 1 h. Bacterial growth in the wells was
indicated by a red–pink colour, whereas clear wells indicated inhibition
of growth by the tested sample.MIC values were recorded as the lowest
concentration of the sample showing a clear well. Each assay was re-
peated twice with two replicates.O
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Fig. 1. Structure of active compound isolated2.7. Antifungal activity
The antifungal activity of the crude extract, fractions and isolated
compound was evaluated against Candida albicans (ATCC 10231) using
the micro-dilution assay (Eloff, 1998) which was modiﬁed for fungi
(Masoko et al., 2007). An overnight fungal culture was prepared in
Yeast Malt (YM) broth. Four millilitres of sterile saline were added
to 400 μL of a 24-h-old C. albicans culture to give approximately
106 CFU/mL of microorganisms. The absorbance was read at 530 nm
and adjusted with sterile saline solution to match that of a 0.5 M
McFarland standard solution. From this prepared stock, a 1:1000 dilu-
tion with sterile YM broth was prepared. The assay was repeated
twice with three replicates each.3. Results and discussion
Structure elucidation of the isolated compound was carried out
using NMR spectroscopic techniques: 1H (400 MHz) and 13C NMR
(100 MHz), and DEPT together with 2D experiments (gCOSY, gHSQC
and gHMBC). Comparison of the 1H and 13C NMR along with the DEPT
spectrum indicated the presence of feruloly group from the ABX pattern
of the aromatic protons and trans oleﬁnic protons. There were two
anomeric protons at δ 5.31 and 4.45 belonging to rhamnosyl and
glucosyl respectively. There was another ABX system assigned to
3,4-dihydroxyphenylethyl group. The positions of the substituents were
assigned based on the HMBC correlations. The compound (Fig. 1) was
identiﬁed as:
Martynoside, 3-Hydroxy-4-methoxyphenethyl 3-O-α-L-
rhamnopyranosyl-4-O-(3-methoxy-4-hydroxy-trans-cinnamoyl)-
β-D-glucopyranoside (1): 1H NMR (MeOD, 400MHz): Aglycone, δ 6.77
(1H, d, J=2.0Hz, H-2), 6.85 (1H, d, J=8.2Hz, H-5), 6.70 (1H, dd, J=8.1,
2.0 Hz, H-6), 2.82 (2H,t, J = 7.4, H-7), 4.04 (1H, dd, J = 17.0 and 7.2 Hz,
H-8), 3.72 (1H, dd, J=17.4 and 7.7Hz, H-8), 3.80 (3H, s, OCH3), glucosyl
Hs, δ 4.45 (1H, d, J = 7.8 Hz, H-1′), 3.45 (1H, t, J = 8.4 Hz, H-2′), 3.89*
(1H, m), 4.93 (1H, t, 9.5 Hz, H-4′), 3.56 (1H, m, H-5′), 3.57 (1H, m,
H-6′), rhamnosyl Hs, δ 5.31 (1H, d, J = 1.3 Hz, H-1″), 3.54 (1H,d,
J = 3.2 Hz, H-2″), 3.87* (1H, m, H-3″), 3.33 (1H, t, J = 9.3 Hz, H-4″),
3.65 (1H, m, H-5″), 1.13 (3H, d, J = 6.2 Hz, H-6″), feruloly, δ 7.35 (1H,
d, J = 1.9 Hz, H-2‴), 6.88 (1H, d, J = 8.2 Hz, H-5‴), 7.16 (1H, dd, J =
8.2, 1.9 Hz, H-6‴), 7.66 (1H, d, J = 15.9 Hz, H-7‴), 6.43 (1H, d, J =
15.9 Hz, H-8‴), 3.92 (3H, s, OCH3). *overlapping of signals
13C NMR (MeOD, 100MHz): Aglycone, δ 132.7 (C-1), 116.8 (CH, C-2),
146.9 (C-3), 147.4 (C-4), 112.6 (CH, C-5), 120.8 (CH, C-6), 36.3 (CH2, C-7),
71.5(CH2, C-8), 56.4 (OCH3), glucosyl Cs, δ 103.9 (CH, C-1′), 76.3 (CH,
C-2′), 79.6 (CH, C-3′), 70.3 (CH, C-4′), 76.0(CH, C-5′),62.4 (CH2, C-6′),
rhamnosyl Cs, δ 101.9(CH, C-1″), 72.3 (CH, C-2″), 72.1 (CH, C-3″),73.7
(CH, C-4″), 69.5 (CH, C-5″), 18.6 (CH3, C-6″), feruloly, δ 127.5 (C-1‴),
111.4 (CH, C-2‴), 148.8 (C-3‴), 150.3 (C-4‴), 116.1 (CH, C-5‴), 124.3
(CH, C-6‴), 146.8 (CH, C-7‴), 115.4 (CH, C-8‴), 167.2 (C = O, C-9‴),
56.4 (OCH3). The spectra data are in good agreement with that of theO
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(martynoside) from Boscia albitrunca.
Table 1
Antimicrobial activity of B. albitrunca extracts and an isolated compound (martynoside)
expressed as (MIC) against the different Gram-positive and Gram-negative bacteria.
Values in bold were considered as noteworthy antimicrobial activity.
Extract (μg/mL) Antibacterial activity MIC (μg/mL) Antifungal activity
(C.a.)
B.s. S.a. E.c. K.p. MIC
μg/mL
MFC
(μg/mL)
Crude extract 3125.0 1560.0 6250.0 6250.0 3125.0 3125.0
Hex 3125.0 3125.0 780.0 1560.0 6250.0 6250.0
DCM 3125.0 6250.0 1560.0 1560.0 1560.0 3125.0
EtOAc 3125.0 780.0 1560.0 3125.0 390.0 780.0
BuOH 390.0 780.0 1560.0 780.0 1560.0 6250.0
Compound (μg/mL)
1 7.81 125.0 125.0 31.2 62.5 250.0
Neomycin (μg/mL)a 1.56 1.56 0.39 0.78
Amphotericin B
(μg/mL)b
0.15 9.80
MIC, minimum inhibitory concentration; MFC, minimum fungicidal concentration; B.s.,
Bacillus subtilis; S.a., Staphylococcus aureus; E.c., Escherichia coli; K.p., Klebsiella pneumoniae.
C.a., Candida albicans Hex, hexane; DCM, dichloromethane; EtOAc, ethyl acetate; BuOH,
butanol.
a Positive control for the antibacterial assay.
b Positive control for the antifungal assay.
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trichotomum (Kim et al., 2001).
The MIC and minimum fungicidal concentration (MFC) values of
B. albitrunca extracts and the isolated compound against the tested
bacteria and C. albicans are presented in Table 1. According to Ríos and
Recio (2005) an MIC value less than 1 mg/mL for crude extracts or
0.1 mg/mL for isolated compounds should be considered effective
and proposed that activity would be very interesting in MICs of
0.1 mg/mL and 0.01 mg/mL for extracts and isolated compounds
respectively. On the other hand, Fabry et al. (1998) described active
crude extracts as those having MIC values b8 mg/mL, whilst Gibbons
(2005) suggests that isolated phytochemicals should have MIC values
b1 mg/mL. In this study, however, MIC and MFC values of less than
1 mg/mL (1000 μg/mL) were considered to be of good activity. All
the extracts showed a broad spectrum of activity against the selected
bacteria with MIC values ranging from 390.0 to 6250.0 μg/mL. The
MIC values of the fractions are lower than that of the standard anti-
bacterial agent (neomycin) used in this study. The butanol fraction
demonstrated the best antibacterial activity (Table 1) with an MIC
value of 390.0 to 1560.0 μg/mL. The traditional uses of the plant for eye
infections are related to bacterial infections. This prompted selection of
the butanol fraction of B. albitrunca which demonstrated the best anti-
bacterial activity for phytochemical investigation in order to target its
bioactive constituent and provide rationale for the ethnomedicinal uses
of the plant. Fractionation of the butanol fraction to target and isolate
its onlymajor compound detected by viewing the TLC proﬁle of the frac-
tion under ultraviolet lamp afforded a phenylpropanoid glycoside identi-
ﬁed as martynoside.
The isolated compound (martynoside) showed good antibacterial
activity with MIC values b250 μg/mL. Of all the samples tested, it was
the most active with the lowest MIC values (7.81 and 31.2 μg/mL)
against B. subtilis and K. pneumonia respectively. Phenylethanoid glyco-
sides like martynoside have previously been reported to have antimi-
crobial activity (Dembitsky, 2005). The activity of martynoside on
B. subtilis and K. pneumoniae is noteworthy though lower than theactivity of the standard antibacterial agent (neomycin). Contamination
of eye drops with the genus Bacillus may cause severe eye infection
and could develop into complete panophthalmitis or endophthalmitis
(Kotiranta et al., 2000; Gerri and Hall, 2006). K. pneumoniae can cause
endophthalmitis, an infection that occurs as a result of seeding of organ-
isms into the interior of the eye following surgery (postoperative),
trauma (post-traumatic) or an infection (Billy and Michelle, 2010). As
indicated in Table 1, the extracts exhibited a broad spectrum of activity
against C. albicans with MIC and MFC values ranging from 390.0 to
6250.0 μg/mL. The ethyl acetate fraction showed good activity with
MIC and MFC values ranging from 390.0 to 780.0 μg/mL. Its MIC and
MFC values are lower than that of the standards (neomycin and
amphotericin B) used in this study. Martynoside showed moderate ac-
tivity against C. albicans with MIC and MFC values ranging from 62.5
to 250.0 μg/mL compared to standard antifungal agent amphotericin
B. According to the WHO (1979) Candida spp. are the most common
causes of endogenous endophthalmitis, leading to scarring of the
chorioretina and blindness.
To the best of our knowledge this is the ﬁrst report on the extracts
and a compound from B. albitrunca and the results observed correspond
with the therapeutic use of this plant in the traditional medicine.
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